Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
University of Chicago
Peking University Third Hospital
Hackensack Meridian Health
Novartis
Institute of Hematology & Blood Diseases Hospital, China
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Celgene
Weill Medical College of Cornell University
Memorial Sloan Kettering Cancer Center
University of California, Davis
Eastern Cooperative Oncology Group
Celgene
Celgene
Academic and Community Cancer Research United
Memorial Sloan Kettering Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Weill Medical College of Cornell University
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Fondazione Italiana Linfomi - ETS
TG Therapeutics, Inc.
Tianjin Medical University Cancer Institute and Hospital
Gilead Sciences
Mayo Clinic
Lund University Hospital
M.D. Anderson Cancer Center
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Celgene
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Celgene
National Cancer Institute (NCI)
Lymphoma Study Association
Lund University Hospital
Fondazione Italiana Linfomi - ETS
Alliance for Clinical Trials in Oncology
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Fondazione Italiana Linfomi - ETS
Mayo Clinic
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center